Saurabh Popat<\/a>, chair of the Empire Club Board of Directors, noted that allied nations are integrating quantum sensing, secure communications, and advanced computing into their core missions. He indicated the shift from concept to capability is visible in initiatives like NORAD modernization, NATO’s emerging quantum strategy, and Canada’s recently released Defense Industrial Strategy. Popat stated defense will be the earliest adopter of these technologies due to significant advantages, warning that Canada must convert its quantum strengths into deployable capability and industrial scale to retain talent, intellectual property, and economic value.<\/p>\nLisa Lambert, CEO of Quantum Industry Canada, said the Defense Industrial Strategy represents a major policy shift, explicitly linking sovereignty, security, and industrial capacity while naming quantum sensing, communications, and computing as sovereign capabilities. She noted the frequent mention of quantum in the document is a deliberate demand signal. Lambert described Canada as moving from assuming security to engineering it and from inventing technologies to anchoring them domestically. While acknowledging Canada’s leading quantum ecosystem faces commercialization challenges, she asserted that with proper alignment, the country can leverage quantum for both defense and economic prosperity. Lambert emphasized the need for continuous engagement between government, military, and industry, strategic investment mirroring allied efforts, and procurement that matches technology maturity to support rapid deployment, noting quantum’s inherently dual-use nature.<\/p>\n
Lieutenant-General Darcy Molstad, the first Commander of the Canadian Joint Forces Command established in late 2025, stated the new Defense Industrial Strategy shows political will and urgency for operationalizing new capabilities and fostering industry-military partnerships. He said the military’s approach to engaging with industry has shifted over the last two years toward collaborative problem-solving on current gaps and challenges to enable rapid operationalization. A current focus is establishing a rapid capabilities unit within his organization that includes advisory capabilities on deep technology and venture capital. Molstad expressed that quantum technologies for defense represent an area where Canada can lead and demonstrate to allies it is a net contributor of security technologies, calling for ambitious national projects.<\/p>\n
Francesco Bova, an associate professor at the University of Toronto’s Rotman School of Management, highlighted that quantum in Canada requires significant external financing, differing from other deep-tech domains due to a frequent lack of recurring revenue and a position still largely within the research and development phase.<\/p>\n
David Roy-Guay, founder and CEO of SBQuantum, discussed the challenge for quantum startups in gaining access to real-world field deployments. His company developed a novel quantum magnetometer for GPS-independent navigation and detecting hidden objects, which was designed in Canada but built elsewhere. He stressed the critical need for companies to deploy in realistic environments to gather feedback, which can then lead to building more capabilities within Canada. His advice to emerging quantum companies is to start small, engage directly with end-users to demonstrate what needs to be built, and cultivate agility for faster delivery than larger global competitors, rather than focusing on perfection.<\/p>\n
Interactive table based on the Store Companies dataset for this report.<\/p>\n
\t\t\t\tSort: Rank
\n\t\t\t\tSort: Company A-Z
\n\t\t\t\tSort: Headquarters A-Z<\/p>\n
\t\t\t\t\t#
\n\t\t\t\t\tCompany
\n\t\t\t\t\tHeadquarters
\n\t\t\t\t\tFocus
\n\t\t\t\t\tScale
\n\t\t\t\t\tNote<\/p>\n
\t\t\t\t\t\t1
\n\t\t\t\t\t\tTRIUMF
\n\t\t\t\t\t\tVancouver, BC
\n\t\t\t\t\t\tCyclotrons, ISOL facilities
\n\t\t\t\t\t\tLarge-scale national lab
\n\t\t\t\t\t\tCanada’s particle accelerator centre<\/p>\n
\t\t\t\t\t\t2
\n\t\t\t\t\t\tAdvanced Cyclotron Systems Inc.
\n\t\t\t\t\t\tRichmond, BC
\n\t\t\t\t\t\tMedical cyclotron manufacturing
\n\t\t\t\t\t\tCommercial medium-scale
\n\t\t\t\t\t\tLeading medical isotope producer<\/p>\n
\t\t\t\t\t\t3
\n\t\t\t\t\t\tBest Cyclotron Systems Inc.
\n\t\t\t\t\t\tVancouver, BC
\n\t\t\t\t\t\tMedical cyclotrons
\n\t\t\t\t\t\tCommercial medium-scale
\n\t\t\t\t\t\tDesigns and manufactures turnkey systems<\/p>\n
\t\t\t\t\t\t4
\n\t\t\t\t\t\tBruce Power
\n\t\t\t\t\t\tTiverton, ON
\n\t\t\t\t\t\tNuclear reactors (Cobalt-60)
\n\t\t\t\t\t\tLarge-scale utility
\n\t\t\t\t\t\tProduces isotopes, not accelerators directly<\/p>\n
\t\t\t\t\t\t5
\n\t\t\t\t\t\tCanadian Light Source
\n\t\t\t\t\t\tSaskatoon, SK
\n\t\t\t\t\t\tSynchrotron light source
\n\t\t\t\t\t\tLarge-scale national facility
\n\t\t\t\t\t\tUses electron accelerator<\/p>\n
\t\t\t\t\t\t6
\n\t\t\t\t\t\tCentre for Probe Development and Commercialization
\n\t\t\t\t\t\tHamilton, ON
\n\t\t\t\t\t\tMedical isotope production
\n\t\t\t\t\t\tResearch\/Commercial
\n\t\t\t\t\t\tUses cyclotrons<\/p>\n
\t\t\t\t\t\t7
\n\t\t\t\t\t\tFusion Pharmaceuticals
\n\t\t\t\t\t\tHamilton, ON
\n\t\t\t\t\t\tTargeted alpha therapies
\n\t\t\t\t\t\tBiotech
\n\t\t\t\t\t\tUtilizes accelerator-produced isotopes<\/p>\n
\t\t\t\t\t\t8
\n\t\t\t\t\t\tARTMS Inc.
\n\t\t\t\t\t\tBurnaby, BC
\n\t\t\t\t\t\tIsotope production technology
\n\t\t\t\t\t\tCommercial
\n\t\t\t\t\t\tProducts for cyclotron-based isotopes<\/p>\n
\t\t\t\t\t\t9
\n\t\t\t\t\t\tKA Imaging
\n\t\t\t\t\t\tWaterloo, ON
\n\t\t\t\t\t\tX-ray imaging technology
\n\t\t\t\t\t\tCommercial
\n\t\t\t\t\t\tUses X-ray sources<\/p>\n
\t\t\t\t\t\t10
\n\t\t\t\t\t\tLinac Technologies
\n\t\t\t\t\t\tSainte-Julie, QC
\n\t\t\t\t\t\tRF power systems for linacs
\n\t\t\t\t\t\tComponent supplier
\n\t\t\t\t\t\tMakes key accelerator components<\/p>\n
\t\t\t\t\t\t11
\n\t\t\t\t\t\tPIPE Nuclear Inc.
\n\t\t\t\t\t\tToronto, ON
\n\t\t\t\t\t\tNuclear system design
\n\t\t\t\t\t\tEngineering
\n\t\t\t\t\t\tAccelerator-related systems<\/p>\n
\t\t\t\t\t\t12
\n\t\t\t\t\t\tRadiant Physics Inc.
\n\t\t\t\t\t\tWaterloo, ON
\n\t\t\t\t\t\tCompact X-ray sources
\n\t\t\t\t\t\tCommercial small-scale
\n\t\t\t\t\t\tDevelops electron accelerators<\/p>\n
\t\t\t\t\t\t13
\n\t\t\t\t\t\tSiemens Healthineers Canada (Cyclotron)
\n\t\t\t\t\t\tOakville, ON
\n\t\t\t\t\t\tMedical cyclotron operation
\n\t\t\t\t\t\tCommercial
\n\t\t\t\t\t\tRadiopharmacy network<\/p>\n
\t\t\t\t\t\t14
\n\t\t\t\t\t\tBWXT Medical Ltd.
\n\t\t\t\t\t\tKanata, ON
\n\t\t\t\t\t\tRadioisotope supply
\n\t\t\t\t\t\tCommercial
\n\t\t\t\t\t\tParent is US, Canadian subsidiary<\/p>\n
\t\t\t\t\t\t15
\n\t\t\t\t\t\tIon Beam Applications (IBA) Canadian Operations
\n\t\t\t\t\t\tLaval, QC
\n\t\t\t\t\t\tParticle therapy systems
\n\t\t\t\t\t\tCommercial large-scale
\n\t\t\t\t\t\tBelgian HQ, significant Canadian ops<\/p>\n
\t\t\t\t\t\t16
\n\t\t\t\t\t\tNordion (Canada)
\n\t\t\t\t\t\tOttawa, ON
\n\t\t\t\t\t\tIsotope supply & processing
\n\t\t\t\t\t\tCommercial
\n\t\t\t\t\t\tProcesses accelerator-produced isotopes<\/p>\n
\t\t\t\t\t\t17
\n\t\t\t\t\t\tUniversity of Alberta (HIAF)
\n\t\t\t\t\t\tEdmonton, AB
\n\t\t\t\t\t\tAccelerator mass spectrometry
\n\t\t\t\t\t\tResearch facility
\n\t\t\t\t\t\tResearch accelerator operator<\/p>\n
\t\t\t\t\t\t18
\n\t\t\t\t\t\tUniversity of British Columbia (AMPEL)
\n\t\t\t\t\t\tVancouver, BC
\n\t\t\t\t\t\tDetector testing beams
\n\t\t\t\t\t\tResearch facility
\n\t\t\t\t\t\tOperates test beam lines<\/p>\n
\t\t\t\t\t\t19
\n\t\t\t\t\t\tUniversity of Saskatchewan (LINAC)
\n\t\t\t\t\t\tSaskatoon, SK
\n\t\t\t\t\t\tLinear accelerator research
\n\t\t\t\t\t\tResearch facility
\n\t\t\t\t\t\tOperates research linac<\/p>\n
\t\t\t\t\t\t20
\n\t\t\t\t\t\tUniversity of Guelph (ACEL)
\n\t\t\t\t\t\tGuelph, ON
\n\t\t\t\t\t\tElectron beam processing
\n\t\t\t\t\t\tResearch facility
\n\t\t\t\t\t\tAccelerator laboratory<\/p>\n
\t\t\t\t\t\t21
\n\t\t\t\t\t\tMcMaster University (ACCL)
\n\t\t\t\t\t\tHamilton, ON
\n\t\t\t\t\t\tNuclear research accelerator
\n\t\t\t\t\t\tResearch facility
\n\t\t\t\t\t\tOperates a tandem accelerator<\/p>\n
\t\t\t\t\t\t22
\n\t\t\t\t\t\tUniversity of Montreal (LASIE)
\n\t\t\t\t\t\tMontreal, QC
\n\t\t\t\t\t\tIon beam analysis
\n\t\t\t\t\t\tResearch facility
\n\t\t\t\t\t\tAccelerator laboratory<\/p>\n
\t\t\t\t\t\t23
\n\t\t\t\t\t\tLaval University (LABEC)
\n\t\t\t\t\t\tQuebec City, QC
\n\t\t\t\t\t\tIon beam analysis
\n\t\t\t\t\t\tResearch facility
\n\t\t\t\t\t\tAccelerator laboratory<\/p>\n
\t\t\t\t\t\t24
\n\t\t\t\t\t\tUniversity of Toronto (EPC)
\n\t\t\t\t\t\tToronto, ON
\n\t\t\t\t\t\tPlasma & accelerator physics
\n\t\t\t\t\t\tResearch lab
\n\t\t\t\t\t\tResearch and development<\/p>\n
\t\t\t\t\t\t25
\n\t\t\t\t\t\tBC Cancer (Cyclotron)
\n\t\t\t\t\t\tVancouver, BC
\n\t\t\t\t\t\tMedical isotope production
\n\t\t\t\t\t\tHealthcare facility
\n\t\t\t\t\t\tOperates cyclotrons<\/p>\n
\t\t\t\t\t\t26
\n\t\t\t\t\t\tLawson Health Research Institute
\n\t\t\t\t\t\tLondon, ON
\n\t\t\t\t\t\tMedical cyclotron operation
\n\t\t\t\t\t\tHealthcare research
\n\t\t\t\t\t\tImaging isotope production<\/p>\n
\t\t\t\t\t\t27
\n\t\t\t\t\t\tCentre Hospitalier Universitaire de Sherbrooke
\n\t\t\t\t\t\tSherbrooke, QC
\n\t\t\t\t\t\tMedical cyclotron
\n\t\t\t\t\t\tHealthcare facility
\n\t\t\t\t\t\tProduces diagnostic isotopes<\/p>\n
\t\t\t\t\t\t28
\n\t\t\t\t\t\tEdmonton PET Centre
\n\t\t\t\t\t\tEdmonton, AB
\n\t\t\t\t\t\tMedical cyclotron operation
\n\t\t\t\t\t\tHealthcare facility
\n\t\t\t\t\t\tCyclotron for radiopharmacy<\/p>\n
\t\t\t\t\t\t29
\n\t\t\t\t\t\tThunder Bay Regional Health (Cyclotron)
\n\t\t\t\t\t\tThunder Bay, ON
\n\t\t\t\t\t\tMedical cyclotron operation
\n\t\t\t\t\t\tHealthcare facility
\n\t\t\t\t\t\tProduces F-18 for imaging<\/p>\n
\t\t\t\t\t\t30
\n\t\t\t\t\t\tNew Brunswick Power (Point Lepreau)
\n\t\t\t\t\t\tFredericton, NB
\n\t\t\t\t\t\tNuclear reactor (Cobalt-60)
\n\t\t\t\t\t\tLarge-scale utility
\n\t\t\t\t\t\tIsotope production potential<\/p>\n
This report provides a comprehensive view of the particle accelerator industry in Canada, tracking demand, supply, and trade flows across the national value chain. It explains how demand across key channels and end-use segments shapes consumption patterns, while also mapping the role of input availability, production efficiency, and regulatory standards on supply.<\/p>\n
Beyond headline metrics, the study benchmarks prices, margins, and trade routes so you can see where value is created and how it moves between domestic suppliers and international partners. The analysis is designed to support strategic planning, market entry, portfolio prioritization, and risk management in the particle accelerator landscape in Canada.<\/p>\n
Quick navigation
\nKey findings<\/p>\n
Domestic demand is shaped by both household and industrial usage, with trade flows linking local supply to imports and exports.
\n Pricing dynamics reflect unit values, freight costs, exchange rates, and regulatory shifts that affect sourcing decisions.
\n Supply depends on input availability and production efficiency, creating a distinct national cost curve.
\n Market concentration varies by segment, creating different competitive landscapes and entry barriers.
\n The 2035 outlook highlights where capacity investment and demand growth are most aligned within the country.
\nReport scope<\/p>\n
The report combines market sizing with trade intelligence and price analytics for Canada. It covers both historical performance and the forward outlook to 2035, allowing you to compare cycles, structural shifts, and policy impacts.<\/p>\n
Market size and growth in value and volume terms
\n Consumption structure by end-use segments
\n Production capacity, output, and cost dynamics
\n Trade flows, exporters, importers, and balances
\n Price benchmarks, unit values, and margin signals
\n Competitive context and market entry conditions
\nProduct coverageProdcom 27904010 – Particle acceleratorsCountry coverageCountry profile and benchmarks<\/p>\n
This report provides a consistent view of market size, trade balance, prices, and per-capita indicators for Canada. The profile highlights demand structure and trade position, enabling benchmarking against regional and global peers.<\/p>\n
Methodology<\/p>\n
The analysis is built on a multi-source framework that combines official statistics, trade records, company disclosures, and expert validation. Data are standardized, reconciled, and cross-checked to ensure consistency across time series.<\/p>\n
International trade data (exports, imports, and mirror statistics)
\n National production and consumption statistics
\n Company-level information from financial filings and public releases
\n Price series and unit value benchmarks
\n Analyst review, outlier checks, and time-series validation<\/p>\n
All data are normalized to a common product definition and mapped to a consistent set of codes. This ensures that comparisons across time are aligned and actionable.<\/p>\n
Forecasts to 2035<\/p>\n
The forecast horizon extends to 2035 and is based on a structured model that links particle accelerator demand and supply to macroeconomic indicators, trade patterns, and sector-specific drivers. The model captures both cyclical and structural factors and reflects known policy and technology shifts in Canada.<\/p>\n
Historical baseline: 2012-2025
\n Forecast horizon: 2026-2035
\n Scenario-based sensitivity to income growth, substitution, and regulation
\n Capacity and investment outlook for major producing companies<\/p>\n
Each projection is built from national historical patterns and the broader regional context, allowing the report to show where growth is concentrated and where risks are elevated.<\/p>\n
Price analysis and trade dynamics<\/p>\n
Prices are analyzed in detail, including export and import unit values, regional spreads, and changes in trade costs. The report highlights how seasonality, freight rates, exchange rates, and supply disruptions influence pricing and margins.<\/p>\n
Price benchmarks by country and sub-region
\n Export and import unit value trends
\n Seasonality and calendar effects in trade flows
\n Price outlook to 2035 under baseline assumptions
\nProfiles of market participants<\/p>\n
Key producers, exporters, and distributors are profiled with a focus on their operational scale, geographic footprint, product mix, and market positioning. This helps identify competitive pressure points, partnership opportunities, and routes to differentiation.<\/p>\n
Business focus and production capabilities
\n Geographic reach and distribution networks
\n Cost structure and pricing strategy indicators
\n Compliance, certification, and sustainability context
\nHow to use this report<\/p>\n
Quantify domestic demand and identify the most attractive segments
\n Evaluate export opportunities and prioritize target destinations
\n Track price dynamics and protect margins
\n Benchmark performance against leading competitors
\n Build evidence-based forecasts for investment decisions<\/p>\n
This report is designed for manufacturers, distributors, importers, wholesalers, investors, and advisors who need a clear, data-driven picture of particle accelerator dynamics in Canada.<\/p>\n
FAQ
\nWhat is included in the particle accelerator market in Canada?<\/p>\n
The market size aggregates consumption and trade data, presented in both value and volume terms.<\/p>\n
How are the forecasts to 2035 built?<\/p>\n
The projections combine historical trends with macroeconomic indicators, trade dynamics, and sector-specific drivers.<\/p>\n
Does the report cover prices and margins?<\/p>\n
Yes, it includes export and import unit values, regional spreads, and a pricing outlook to 2035.<\/p>\n
Which benchmarks are included?<\/p>\n
The report benchmarks market size, trade balance, prices, and per-capita indicators for Canada.<\/p>\n
Can this report support market entry decisions?<\/p>\n
Yes, it highlights demand hotspots, trade routes, pricing trends, and competitive context.<\/p>\n
\t\t\t\t\t\t1. INTRODUCTION<\/p>\n
Report Scope and Analytical Framing<\/p>\n
Report DescriptionResearch Methodology and the Analytical FrameworkData-Driven Decisions for Your BusinessGlossary and Product-Specific Terms2. EXECUTIVE SUMMARY<\/p>\n
Concise View of Market Direction<\/p>\n
Key FindingsMarket TrendsStrategic ImplicationsKey Risks and Watchpoints3. DOMESTIC MARKET SIZE AND DEVELOPMENT PATH<\/p>\n
Market Size, Growth and Scenario Framing<\/p>\n
Market Size: Historical Data (2012-2025) and Forecast (2026-2035)Growth Outlook and Market Development Path to 2035Growth Driver DecompositionScenario Framework and Sensitivities4. CATEGORY SCOPE, DEFINITIONS AND BOUNDARIES<\/p>\n
Commercial and Technical Scope<\/p>\n
What Is Included and How the Market Is DefinedMarket Inclusion CriteriaProduct \/ Category DefinitionExclusions and BoundariesDistinction From Adjacent Products and Substitute Categories5. CATEGORY STRUCTURE, SEGMENTATION AND PRODUCT MATRIX<\/p>\n
How the Market Splits Into Decision-Relevant Buckets<\/p>\n
By Product Type \/ ConfigurationBy Application \/ End UseBy Customer \/ Buyer TypeBy Channel \/ Business Model \/ Technology PlatformSegment Attractiveness MatrixProduct Matrix and Segment Growth Logic6. DOMESTIC DEMAND, CUSTOMER AND BUYER ARCHITECTURE<\/p>\n
Where Demand Comes From and How It Behaves<\/p>\n
Consumption \/ Demand: Historical Data (2012-2025) and Forecast (2026-2035)Demand by End-Use and Buyer GroupDemand by Customer \/ Consumer SegmentPurchase Criteria, Switching Logic and Adoption BarriersReplacement, Replenishment and Installed-Base DynamicsFuture Demand Outlook7. DOMESTIC PRODUCTION, SUPPLY AND VALUE CHAIN<\/p>\n
Supply Footprint and Value Capture<\/p>\n
Production in the CountryDomestic Manufacturing FootprintCapacity, Bottlenecks and Supply RisksValue Chain Logic and Margin PoolsDistribution and Route-to-Market Structure8. IMPORTS, EXPORTS AND SOURCING STRUCTURE<\/p>\n
Trade Flows and External Dependence<\/p>\n
ExportsImportsTrade BalanceImport DependenceSourcing Risks and Resilience9. PRICING, PROMOTION AND COMMERCIAL MODEL<\/p>\n
Price Formation and Revenue Logic<\/p>\n
Domestic Price Levels and CorridorsPricing by Segment \/ Specification \/ ChannelCost Drivers and Margin LogicPromotion, Discounting and Procurement PatternsRevenue Quality and Commercial Levers10. COMPETITIVE LANDSCAPE AND PORTFOLIO POWER<\/p>\n
Who Wins and Why<\/p>\n
Market Structure and ConcentrationCompetitive ArchetypesSegment-by-Segment Competitive IntensityPortfolio Breadth and Product PositioningCapability MatrixStrategic Moves, Partnerships and Expansion Signals11. DOMESTIC MARKET STRUCTURE AND CHANNEL LOGIC<\/p>\n
How the Domestic Market Works<\/p>\n
Core Demand CentersLocal Production and Distribution RolesChannel StructureBuyer and Procurement ArchitectureRegional Imbalances Within the Country12. GROWTH PLAYBOOK AND MARKET ENTRY<\/p>\n
Commercial Entry and Scaling Priorities<\/p>\n
Where to PlayHow to WinDistributor \/ Partner \/ Direct Entry OptionsCapability ThresholdsEntry Risks and Mitigation13. WHERE TO PLAY NEXT: MOST ATTRACTIVE GROWTH OPPORTUNITIES<\/p>\n
Where the Best Expansion Logic Sits<\/p>\n
Most Attractive Product NichesMost Attractive Customer SegmentsWhite Spaces and Unsaturated OpportunitiesHigh-Margin and Underpenetrated PocketsMost Promising Product Adjacencies14. PROFILES OF MAJOR COMPANIES<\/p>\n
Leading Players and Strategic Archetypes<\/p>\n
Leading Manufacturers and SuppliersProduction Footprint and CapacitiesProduct Portfolio and Segment FocusPricing Positioning and Indicative Price LogicChannel \/ Distribution StrengthStrategic Archetypes15. METHODOLOGY, SOURCES AND DISCLAIMER<\/p>\n
How the Report Was Built<\/p>\n
Modeling LogicSource RegisterPublications, Regulatory and Industry ReferencesAnalytical NotesDisclaimer\t\t\t\t\t<\/p>\n
Loading News content from Store report…<\/p>\n
\t\t\t\t\t\t\t\t\t\t\t\t\tTRIUMF<\/p>\n
Canada’s particle accelerator centre<\/p>\n
Advanced Cyclotron Systems Inc.<\/p>\n
Leading medical isotope producer<\/p>\n
Best Cyclotron Systems Inc.<\/p>\n
Designs and manufactures turnkey systems<\/p>\n
Bruce Power<\/p>\n
Produces isotopes, not accelerators directly<\/p>\n
Canadian Light Source<\/p>\n
Uses electron accelerator<\/p>\n
Centre for Probe Development and Commercialization<\/p>\n
Uses cyclotrons<\/p>\n
Fusion Pharmaceuticals<\/p>\n
Utilizes accelerator-produced isotopes<\/p>\n
ARTMS Inc.<\/p>\n
Products for cyclotron-based isotopes<\/p>\n
KA Imaging<\/p>\n
Uses X-ray sources<\/p>\n
Linac Technologies<\/p>\n
Makes key accelerator components<\/p>\n
PIPE Nuclear Inc.<\/p>\n
Accelerator-related systems<\/p>\n
Radiant Physics Inc.<\/p>\n
Develops electron accelerators<\/p>\n
Siemens Healthineers Canada (Cyclotron)<\/p>\n
Radiopharmacy network<\/p>\n
BWXT Medical Ltd.<\/p>\n
Parent is US, Canadian subsidiary<\/p>\n
Ion Beam Applications (IBA) Canadian Operations<\/p>\n
Belgian HQ, significant Canadian ops<\/p>\n
Nordion (Canada)<\/p>\n
Processes accelerator-produced isotopes<\/p>\n
University of Alberta (HIAF)<\/p>\n
Research accelerator operator<\/p>\n
University of British Columbia (AMPEL)<\/p>\n
Operates test beam lines<\/p>\n
University of Saskatchewan (LINAC)<\/p>\n
Operates research linac<\/p>\n
University of Guelph (ACEL)<\/p>\n
Accelerator laboratory<\/p>\n
McMaster University (ACCL)<\/p>\n
Operates a tandem accelerator<\/p>\n
University of Montreal (LASIE)<\/p>\n
Accelerator laboratory<\/p>\n
Laval University (LABEC)<\/p>\n
Accelerator laboratory<\/p>\n
University of Toronto (EPC)<\/p>\n
Research and development<\/p>\n
BC Cancer (Cyclotron)<\/p>\n
Operates cyclotrons<\/p>\n
Lawson Health Research Institute<\/p>\n
Imaging isotope production<\/p>\n
Centre Hospitalier Universitaire de Sherbrooke<\/p>\n
Produces diagnostic isotopes<\/p>\n
Edmonton PET Centre<\/p>\n
Cyclotron for radiopharmacy<\/p>\n
Thunder Bay Regional Health (Cyclotron)<\/p>\n
Produces F-18 for imaging<\/p>\n
New Brunswick Power (Point Lepreau)<\/p>\n
Isotope production potential<\/p>\n
Loading Reviews content from Store report…<\/p>\n
Loading Dashboard content from Store report…<\/p>\n
Loading Macro Indicators content from Store report…<\/p>\n","protected":false},"excerpt":{"rendered":"Apr 17, 2026 According to a report from EETimes, quantum technologies are seen as foundational to modern defense…\n","protected":false},"author":2,"featured_media":8505,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[17,4783,4786,4789,4791,4790,4788,4787,4785,4784],"class_list":{"0":"post-8504","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-canada","8":"tag-canada","9":"tag-canada-defense","10":"tag-defense-industrial-strategy","11":"tag-military-technology","12":"tag-nato-quantum-strategy","13":"tag-norad-modernization","14":"tag-quantum-communications","15":"tag-quantum-computing","16":"tag-quantum-sensing","17":"tag-quantum-technology"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/posts\/8504","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/comments?post=8504"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/posts\/8504\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/media\/8505"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/media?parent=8504"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/categories?post=8504"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/tags?post=8504"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}